MARKHAM - OCTOBER 23 - Nurse Susan Cousins preps Johann Kerlow (seated) for her first infusion of Soliris at her home. She has a rare disease and needs access to Soliris for life, but the $500,000 a year drug is not funded by the government. Trillium fund is helping Krantz get the medication. Her first infusion took place on October 23, 2014. (Rick Madonik/Toronto Star via Getty Images)
MARKHAM - OCTOBER 23 - Nurse Susan Cousins preps the vials of Soliris before beginning the infusion of Johann Kerlow. Kerlow has a rare disease and needs access to Soliris for life, but the $500,000 a year drug is not funded by the government. Trillium fund is helping Krantz get the medication. Her first infusion took place on October 23, 2014. (Rick Madonik/Toronto Star via Getty Images)
MARKHAM - OCTOBER 23 - Soliris, the drug Johann Kerlow needs to sustain her. Kerlow has a rare disease and needs access to Soliris for life, but the $500,000 a year drug is not funded by the government. Trillium fund is helping Krantz get the medication. Her first infusion took place on October 23, 2014. (Rick Madonik/Toronto Star via Getty Images)
MARKHAM - OCTOBER 23 - Nurse Susan Cousins preps the vials of Soliris before beginning the infusion of Johann Kerlow. Kerlow has a rare disease and needs access to Soliris for life, but the $500,000 a year drug is not funded by the government. Trillium fund is helping Krantz get the medication. Her first infusion took place on October 23, 2014. (Rick Madonik/Toronto Star via Getty Images)
MARKHAM - OCTOBER 23 - Nurse Susan Cousins checks the vital signs of Johann Kerlow, who is undergoing an infusion of Soliris. Kerlow has a rare disease and needs access to Soliris for life, but the $500,000 a year drug is not funded by the government. Trillium fund is helping Krantz get the medication. Her first infusion took place on October 23, 2014. (Rick Madonik/Toronto Star via Getty Images)
